Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US7452916B2 · kind B2 · utility
14Cited by
66References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 22, 2004 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Dec 22, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Endothelial nitric oxide production is enhanced by administration of arginine or lysine as a dietary supplement. Enhanced nitric oxide production from arginine supplementation improves vascular function and structure. Additional compounds may be administered with arginine or lysine to further enhance nitric oxide activity, including calcium, vitamin B6, vitamin B12, vitamin C, vitamin B, coenzyme Q, carotene, or glutathione.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.